A weekend of consolidation after a record-breaking week. SpaceX completed the largest IPO in history and closed its first session ~19% above the $135 issue price, vaulting past Tesla as Musk’s most valuable holding and confirming him as the world’s first trillionaire — even as Bloomberg’s own columnists and short-seller Jim Chanos call it a warning sign for froth. On the geopolitics that has driven markets all month, Washington and Tehran now say they are edging toward signing an interim deal around next week’s G7: half of the Strait of Hormuz’s blocked flows are reportedly restored and crude sits at a three-month low. The counter-currents are still there underneath: the ECB is openly split (one hawk wants more hikes, markets are starting to bet on cuts), Fed rate-cut expectations have been pushed out to 2027, and private credit is visibly gating — a BlackRock fund met under 40% of redemption requests for a second straight quarter.
It’s Saturday — US and European cash markets are shut for the weekend. Index levels in the snapshot are the most recent Bloomberg “Top Securities” reads; the live weekend ticker did not refresh Friday’s exact close in this morning’s read, so the equity prints shown are the prior (Thu 11 Jun) close — and Friday’s session finished higher still (stocks climbed again on US–Iran optimism and SpaceX’s blockbuster debut). Oil, gold, FX and rates reflect the week’s relief move (crude at a three-month low, gold’s war premium unwinding, the dollar firm). The live swing factors into Monday: whether the US–Iran interim deal is actually signed around the G7, SpaceX’s follow-through after its debut, and next week’s Fed (Warsh’s first) and BOJ decisions.
Top of the morning
SpaceX closes its debut ~19% higher; Musk crowned first trillionaire — and the skeptics get loud
After pricing the record $75bn IPO at $135, SpaceX rose about 19% on its first day, overtaking Tesla as the most valuable company in Musk’s empire and tipping him three times richer than his nearest rival. Notably it negotiated a rare $0 fee to banks on the greenshoe. The counter-narrative is now just as loud: Bloomberg’s Big Take asks why Musk rushed to list, Chris Hughes calls the SpaceX–Anthropic–OpenAI tangle “a cocktail with a hangover,” and Jim Chanos frames the listing as a troubling top-signal for the whole speculative complex.
US and Iran edge toward signing an interim deal near the G7; half of Hormuz flows restored
The proposed agreement — built on a “sequenced rewards” structure that both Washington and Tehran call fragile — is expected to be signed close to next week’s G7, with US officials vowing it will reopen the Strait of Hormuz and end the nuclear threat. The energy chief says roughly half of the blocked shipping flows are already back. Caveats remain heavy: Iran is reported to have rebuilt its missile arsenal (likely with Russian-made stock), shipowners are still wary of “dark” oil cargoes, and the IAEA is prioritising inspections.
Friday extended the relief rally: stocks up on Iran optimism, oil at a three-month low, gold sliding
US equities climbed again into the close as the war premium drained out of risk assets and SpaceX debuted. Crude sits near a three-month low on the de-escalation; gold is heading for its worst quarter in nearly a decade as the haven trade unwinds; and traders are now the most positive on the dollar since early 2025. With cash markets shut for the weekend, those are the levels that carry into Monday unless the Iran headlines turn.
The ECB splits in public; Fed rate-cut bets get pushed all the way out to 2027
Days after the ECB’s first hike since 2023 (to 2.25%), hawk Peter Kazimir argued rates must rise further to tame inflation — even as other investors started betting the bank pivots to cuts as growth slows. On the US side, a survey now pushes expected Fed cuts into 2027, and new chair Kevin Warsh’s inaugural meeting on Wednesday is not expected to ease. The Bundesbank, for its part, says German spending should keep the economy growing in 2026 despite the war.
Private credit keeps gating — the clearest crack under the AI-capex boom
BlackRock’s $13bn HPS corporate lending fund honoured less than 40% of redemption requests for a second consecutive quarter, the sharpest sign yet of strain as retail investors eye the exits from private credit. Credit traders also unwound a roughly $20bn “wartime” short in Europe as the Iran premium faded. The backdrop to a frantic financing stretch (SpaceX, a $41bn Bezos AI lab, Mistral reportedly raising near €20bn) is a private-credit market that is starting to ration liquidity.
UK politics wobbles: Starmer’s premiership teeters, Burnham circles; Europe braces for NATO cuts
A day after defence secretary John Healey’s scathing resignation, Bloomberg reports Greater Manchester mayor Andy Burnham is planning a swift power grab as Starmer’s position weakens. Separately, European capitals are bracing for drastic cuts to US wartime contributions to NATO, sharpening the continent’s defence-funding dilemma — the same squeeze that just felled a UK cabinet minister and that European defence stocks have started to price.
AI’s policy and antitrust front opens up — Anthropic pulls models, OpenAI probed, China pushes back
The Trump administration directed Anthropic to bar foreign access to its newest models on national-security grounds, prompting the company to suspend them; a coalition of state attorneys-general opened a probe into OpenAI; and Beijing rebuked Washington over the “military” labelling of its top firms. The throughline for the AI-capex trade: the buildout is now colliding with export controls, antitrust and geopolitics, not just compute supply.
FT portfolio signal · tied to your holdings
What FT flagged for your book
Macro / regime read. The tape is still a relief rally, and it has extended — the energy tail is the reason. Crude at a three-month low, half of Hormuz reportedly reopened and an interim Iran deal edging toward signing all pull the single biggest input out of the inflation/rate regime. But the rate picture is now openly contested rather than one-directional: FT’s “tame the inflation python” piece warns a wait-and-see central bank risks repeating 2008-style mistakes, the ECB is visibly split (Kazimir wants more, markets begin to price cuts on slowing growth), and US cut expectations have slid out to 2027 — a tug-of-war between sticky inflation and softening growth that keeps high-multiple names two-sided. The clearest credit signal is the one to respect: BlackRock’s HPS fund gating redemptions below 40% for a second quarter, retail exiting private credit, and a $20bn European wartime short being unwound — strain that is real but not yet a systemic break. War-chest deployment rules stay sheathed: nothing here trips a severe trigger, and the bounce pulls further from one. Respect the regime; the private-credit gating is the line to watch.
AI capex (theme — your semis/cloud shelf). FT’s Robert Armstrong (“AI is revolutionising the stock market”) tags Microsoft, Amazon and Alphabet directly, with a pointed thesis: Big Tech no longer self-funds the buildout and increasingly needs external capital — making the leaders more confidence-sensitive than the price action suggests. Katie Martin’s companion piece on AI reshaping allocation, plus the SpaceX–Anthropic–OpenAI financing nexus and Mistral’s ~€20bn round, all point to durable compute demand riding on a growing slug of private credit. Read-through to the custom-silicon and lithography shelf (Broadcom, ASML) stays intact; the watch-item is the funding source, not the demand.
Healthcare (sector — your defensive sleeve). FT profiles GSK’s $10.6bn cancer-biotech acquisition, its biggest in 25+ years — a signal that large-cap pharma M&A is reopening (relevant read-across for the healthcare sleeve even though GSK isn’t a held name). Separately, the Palantir/NHS controversy keeps health-data politics live. No GLP-1 (Novo Nordisk / Eli Lilly), UnitedHealth, Vertex, Thermo Fisher or Intuitive Surgical single-name items in the feed today.
Semiconductors (theme). FT’s Lex argues European “tech sovereignty” is a doubtful strategic goal but a decent investment given the low base — a read-through to ASML and the EU chip-subsidy complex. No standalone ASML or Broadcom catalyst in the window.
Payments / consumer / Berkshire — quiet. No Visa, Mastercard, Berkshire, Caterpillar, Deere, Booking, Nike or Costco single-name items in the FT feed today.
Shelf single-names live today: Microsoft, Amazon and Alphabet — but only thematically, inside FT’s AI-capex column, not as standalone catalysts. The actionable read stays theme-level: durable AI-compute demand (SpaceX’s debut, the AI financing wave) set against a contested-rate backdrop and visibly rationing private credit.
Net: the relief rally has legs — softer oil and an Iran deal in sight ease the stagflation tail — but a split ECB, a no-cut-until-2027 Fed and private-credit funds gating redemptions keep the regime defensive-to-neutral. No severe trigger, so war-chest rules stay sheathed. Watch-lines: whether the Iran interim deal is signed around the G7, SpaceX’s follow-through, the private-credit gating, and next week’s Fed (Warsh) and BOJ decisions.
Markets snapshot
Weekend read — US and European cash markets are closed. Equity rows are the most recent Bloomberg “Top Securities” levels the ticker displayed (the prior Thu 11 Jun close); Friday’s session closed higher still on US–Iran optimism and SpaceX’s +19% debut, but the weekend ticker did not surface Friday’s exact print. Oil, gold, FX and rates show the week’s relief move.
Instrument
Last
Move / context
S&P 500
7,394.30
Thu close on ticker · Fri extended higher (Iran + SpaceX)
Nasdaq
25,809.66
Thu close · Fri rose again, tech / AI-led
Bloomberg 500
2,672.53
Thu close · broad risk-on into the weekend
FTSE 100
10,303.88
Thu close · firm despite UK GDP −0.1%, Flutter exit
US 10-year Treasury
~4.47%
war premium easing as oil falls; Fed-cut bets slip to 2027
EUR/USD
~1.16
dollar firmest positioning since Feb 2025
GBP/USD
~1.34
capped by UK political wobble (Starmer / Burnham)
Crude Oil (WTI)
~$86
three-month low · Hormuz half-restored, interim deal near
Gold (spot)
~$4,200
war premium unwinds · worst quarter in ~a decade
Levels transcribed from the Bloomberg Europe ticker. On the weekend the equity prints carry the last displayed close; the homepage confirms Friday ended higher (“stocks climb on US–Iran optimism as SpaceX debuts”, SpaceX +19%). Crude, gold, FX and rates reflect the live relief move — oil and gold lower as the war premium unwinds, the dollar firm. Next catalysts: the Iran interim-deal signing around the G7 and SpaceX’s follow-through.
Global markets & macro
The week ended with the war premium still draining out of markets. Trump’s climb-down from a fresh round of Iran strikes and the move toward an interim deal — now expected to be signed around next week’s G7, with roughly half of the Strait of Hormuz’s blocked flows reportedly restored — pulled crude to a three-month low and sent equities higher again on Friday. Gold is sliding toward its worst quarter in nearly a decade as the haven trade unwinds, and positioning has flipped to the most dollar-positive since early 2025. But the policy backdrop is genuinely two-sided now. The ECB, fresh off its first hike since 2023 (to 2.25%), is split in public: Kazimir wants to go further on inflation while other investors have begun betting the bank pivots to cuts as growth softens. In the US, the consensus for Fed easing has slipped out to 2027, and Kevin Warsh’s first meeting as chair on Wednesday is not expected to deliver a cut — even as consumer sentiment ticked up on cheaper gasoline.
Sitting above all of it is the capital-markets event of the year, now realised: SpaceX completed its record $75bn IPO and closed its first session about 19% above the $135 price, overtaking Tesla as Musk’s most valuable company and confirming him as the first trillionaire. The reception was euphoric, but the commentary has turned more cautious — Bloomberg’s columnists and Jim Chanos read the listing as a sign of speculative froth (the “manic impulsiveness” of a SpaceX-fuelled retail complex), and the same paradox recurs: this wave of equity and private-credit supply is a confidence vote in the AI buildout, yet it drains liquidity from existing names and concentrates risk in private credit just as that market starts to ration it. BlackRock’s HPS fund gating redemptions below 40% for a second quarter, retail investors heading for the private-credit exits, and a $20bn European wartime short being unwound are the cracks worth watching. In Asia, the strain is still visible — India has shifted into “crisis mode” with fuel curbs and a wider deficit, Indonesia’s rupiah keeps hitting record lows, and the BOJ is set for a landmark move to 1% next week even with Governor Ueda sidelined by illness.
Geopolitics & world news
The Middle East still sets the tape, and the direction is toward de-escalation — cautiously. After a fortnight that ran from a downed US helicopter and reciprocal strikes to a threat to seize Iran’s Kharg Island oil hub, Washington and Tehran now say an interim deal is close, likely to be signed around next week’s G7, with the Strait of Hormuz to reopen on signing. The structure rests on “sequenced rewards” that both sides concede is fragile, Iran is reported to have quietly rebuilt its missile arsenal with Russian-made stock, and shipowners remain wary — so markets are pricing relief while the agreement is still unsigned. Elsewhere, the US said it killed the leader of the Venezuelan Tren de Aragua gang in a strike on a compound, Beijing rebuked Washington over the “military” labelling of its top firms, and the ICC ordered another health check for former Philippine leader Duterte.
In Europe, politics is the story: the UK lost its defence secretary in a public spending row and Bloomberg now reports Andy Burnham manoeuvring as Starmer’s premiership teeters, while the continent braces for drastic cuts to US wartime contributions to NATO — the funding squeeze European defence stocks have started to price. Switzerland votes tomorrow on a first-of-its-kind population cap (9.5m). For the medical reader, a few threads are worth a longer look on a calmer day: FT and Bloomberg both flag the return of Ebola in the DR Congo as a warning shot for pandemic preparedness at a moment of shrinking global health budgets and a worrying lack of readiness for “Disease X”; GSK’s $10.6bn cancer-biotech deal signals large-cap pharma is buying growth again; and Bloomberg’s feature on how extreme heat — amplified by a looming “super” El Niño — is starting to sap productivity in labour-intensive economies like India.
Today & week ahead (CET)
Sat 13Weekend — cash markets closed. Watch the Iran headlines (any move toward signing the interim deal / Hormuz status) and SpaceX commentary into Monday
Sun 14Swiss referendum on a first-of-its-kind population cap (9.5m) · World Cup continues across North America (US opened with a 4–1 win)
Next wkG7 summit — the US–Iran interim deal is expected to be signed around it; the key risk event for oil and the relief rally
Wed 17Fed decision — Kevin Warsh’s first meeting as chair; no cut expected (CPI ~4.2%, easing sentiment) · BOJ also meets next week, expected to lift to 1% (Ueda ill, set to miss it)